ATLANTIC BIOLOGICALS CORP.

Atlantic Biologicals Corp. specializes in the distribution and logistics of biological and life sciences materials, leveraging its expertise in cold-chain transport, biospecimen handling, and regulated supply chain management. The company provides end-to-end solutions for the secure movement of temperature-sensitive biological samples, reagents, and diagnostic materials, ensuring compliance with federal biosafety and chain-of-custody standards. Technical capabilities include validated packaging systems, real-time environmental monitoring, and documentation compliance for regulated transport under DOT, CDC, and WHO guidelines. Their operational focus centers on precision logistics for research, clinical, and public health applications, with a demonstrated ability to manage high-integrity biological materials across complex federal and institutional networks. Award history is not available to determine specific agency relationships or recent contract performance. Consequently, no verifiable patterns of engagement with federal departments or programs can be confirmed. The company operates under NAICS 424210, which classifies it as a wholesale distributor of medical and surgical supplies, including biological products. In practice, this translates to serving as a critical intermediary between manufacturers and end-users in biomedical research, clinical diagnostics, and public health infrastructure. The firm’s market positioning is grounded in reliable, compliant distribution of sensitive biological inventory, supporting laboratories, hospitals, and government research entities that require uninterrupted access to validated materials. Atlantic Biologicals Corp. is structured as a small business (2L entity) headquartered in Miami, Florida, with no federal certifications on record. Its geographic presence is centered in the southeastern United States, supporting regional demand for biological logistics while maintaining flexibility to serve national networks. The company’s business model emphasizes operational integrity, regulatory adherence, and supply chain resilience in the life sciences sector.